AGP Picks
View all

Riyadh to host global biotech leaders for RGMBS 2026

7 hours ago
By AI, Created 04:29 UTC, Aug 10, 2026, AGP -

Riyadh will host the fourth Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026, bringing together more than 100 speakers, 70 delegations and thousands of attendees. The event is designed to advance Saudi Arabia’s biotech strategy, with a focus on AI, genomics, manufacturing, regulation and investment.

Why it matters: - The summit is tied to Saudi Arabia’s National Biotechnology Strategy, which aims to add $34.6 billion to non-oil GDP by 2040. - Organizers are using RGMBS 2026 to position Riyadh as a regional and global hub for biotech innovation, investment and talent. - The event is meant to connect research, regulation, manufacturing and capital across the biotech value chain.

What happened: - Riyadh Global Medical Biotechnology Summit 2026 will take place in Riyadh, Saudi Arabia, from Sept. 14-16, 2026. - The fourth edition will bring together scientists, investors, policymakers and health innovators. - More than 100 local and international speakers are expected. - More than 70 country delegations are expected to attend. - Registration is open for delegates, exhibitors and industry partners. - Event information, the scientific program and speaker list are available on rgmbs.org.

The details: - The summit will cover six themes: artificial intelligence in biotech, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and specialized workforce development. - Organizers expect more than 15,000 visitors. - The event will feature 200 biotech and healthcare brands. - More than 80 government and industry exhibitors are expected. - Organizers aim to sign more than 65 agreements and memorandums of understanding during the three-day summit. - The scientific program spans population-scale genomics, AI drug discovery, local biologics production, regulatory science, commercialization and investment. - The summit includes sessions, panel discussions, workshops and agreement signings. - International delegates will see Saudi Arabia’s regulatory framework, manufacturing infrastructure and translational research capacity. - The summit is held under the supervision of the Ministry of National Guard, Health Affairs sector. - King Abdullah International Medical Research Center and King Saud bin Abdulaziz University for Health Sciences are hosting the event. - The Ministry of Investment, Invest Saudi and the Saudi Data & AI Authority are strategic partners. - S.E. Prof. Bandar Alknawy said this year’s theme is “Building Foundations for Biotech Excellence.” - Alknawy said the summit is highlighting structural depth after a previous focus on global reach. - Alknawy pointed to partnerships with Harvard University in translational oncology, AstraZeneca in gene therapy and Peking University in pharmaceutical research. - Alknawy said advanced labs, integrated research centers, clinical trial networks, biologics manufacturing and digital platforms are essential to the ecosystem. - Alknawy also said national talent development and leadership across academia, industry and regulation are critical.

Between the lines: - The summit reflects a shift from broad biotech ambition to building the infrastructure needed to commercialize research. - Saudi Arabia is emphasizing end-to-end capability, from discovery to commercial-scale production, rather than isolated research wins. - The international partnerships signal an effort to validate the country’s biotech push through collaboration with major global institutions.

What’s next: - The summit will run for three days in September, with announcements likely centered on partnerships, deals and policy cooperation. - Organizers are expected to use the event to advance biotech investment and workforce development goals. - Follow updates through the #RGMBS2026 hashtag and the summit’s official channels.

The bottom line: - Riyadh is turning RGMBS 2026 into a showcase for Saudi Arabia’s biotech ambitions, with scale, policy backing and global partnerships all aimed at building a deeper life-sciences ecosystem.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

World Governments Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Governments Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.